In the Evolving Mystery of BV, an Innovative Oral Treatment Emerges

This supplement is sponsored by Symbiomix Therapeutics, LLC (a Lupin Company).


Click Here to Read the Supplement

Topics include:

  • BV terminology and treatment over time
  • Current understanding of BV etiology
  • BV consequences
  • BV treatments
  • Future research needs in BV

Steven E. Chavoustie, MD, FACOG, CCRP

University of Miami

Miller School of Medicine

Miami, Florida

Click Here to Read the Supplement

Next Article: